TAMPA, Fla.--(BUSINESS WIRE)--Validic Inc., a market-leading digital health and personalized care company, continues to expand its healthcare IoT platform with the integration of Smart Meter. This integration brings exclusive cellular-enabled, patient-...
Japanese Product Now Under Review for Nationwide Marketing ApprovalBOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that its Japanese partner Shionogi & Co. Ltd has submitted Akili’s digital ...
Tuned, a digital hearing health company providing preventive and comprehensive hearing health for employers, today announced it secured an oversubscribed $3.2 million seed extension led by Unum Group, with participation from Distributed Ventures.
CHICAGO--(BUSINESS WIRE)--Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications, today announced its entry into the Medicare market. The company will offer health plans that support Medicare beneficiaries customizable configurations of its proprietary Marketplace Search technology, which lowers prescription drug prices for members and improves their experience, while also providing health plans with critical insight into adherence trends.
Talkspace, a leading online behavioral health company, and Wheel, the foremost virtual care platform powering the next generation of virtual healthcare, announced they will partner to offer patients access to board-certified general practitioners and licensed behavioral health providers across the U.S. – conveniently and virtually.
Aptar Digital Health, a global leader in digital health solutions (Software as a Medical Device (SaMD) and digital Patient Support Programs), connected devices and disease management, today announced that it has acquired Healint, a digital health company recognized for their virtual clinical studies, real-world evidence and patient registries platform, as well as the Migraine Buddy and Clarrio mobile apps, which support patients suffering from neurological and immunological conditions.
The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced that it will be showcasing the breadth of its specialized digital solutions and the latest advancements in its cellular therapy and transplant monitoring pipeline at the 2024 Tandem Meetings, Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®, being held February 21-25 in San Antonio, Texas.
A recent study conducted by California Home Abortion by Telehealth (CHAT) sheds lig…
Department of Health and Human Services recognizes innovative program with proven outcomes for improving postpartum care for at-risk mothers in Nebraska for a second timeOMAHA, Neb.--(BUSINESS WIRE)--CyncHealth, the designated health information excha...
MRM Health, a clinical-stage biopharmaceutical company, announced today that it has received regulatory and ethics committee approval to start an observational, cross-sectional clinical trial to study the role of the small intestinal microbiome in Parkinson’s Disease (PD) and to identify PD-specific microbial and metabolic fingerprints in small intestinal fluid and blood. The clinical research is being conducted in close collaboration with Nimble Science and the University of Calgary, Canada.